Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Todd Fox

9PUBLICATIONS

27CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGlycoconjugatesMedical biochemistry - lipidsLiquid biopsies

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Sep 02, 2025

Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma.

Ipsita Pal, Anuradha Illendula, Andrea Joyner

|Mar 13, 2024

Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells.

Yuki Ohya, Yuri Ogiso, Masaya Matsuda

|Dec 23, 2023

Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia.

Johnson Ung, Su-Fern Tan, Todd E Fox

|Mar 29, 2023

Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia.

Kelsey H Fisher-Wellman, Miki Kassai, James T Hagen

|Feb 25, 2023

Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma.

Harumi Sakae, Yuri Ogiso, Masaya Matsuda

|Sep 15, 2022

Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia.

Andrei V Khokhlatchev, Arati Sharma, Tye G Deering

Pageof 2

Frequent Collaborators

3 joint publications

David J Feith

2 joint publications

David F Claxton

2 joint publications

Upendarrao Golla

2 joint publications

Johnson Ung

2 joint publications

Masaya Matsuda

2 joint publications

Kazuyuki Kitatani

1 joint publications

Jose Luis Abad

1 joint publications

Hong-Gang Wang

1 joint publications

Jeremy J P Shaw

1 joint publications

Timothy L Boyer

Frequent Collaborators

3 joint publications

David J Feith

2 joint publications

David F Claxton

2 joint publications

Upendarrao Golla

2 joint publications

Johnson Ung

Top Related Videos

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on : Sep 20, 2017

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on : Nov 01, 2017

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos

Top Related Videos

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on : Sep 20, 2017

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on : Nov 01, 2017

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos